MX2016002922A - Metodos para la deteccion de enfermedad renal. - Google Patents

Metodos para la deteccion de enfermedad renal.

Info

Publication number
MX2016002922A
MX2016002922A MX2016002922A MX2016002922A MX2016002922A MX 2016002922 A MX2016002922 A MX 2016002922A MX 2016002922 A MX2016002922 A MX 2016002922A MX 2016002922 A MX2016002922 A MX 2016002922A MX 2016002922 A MX2016002922 A MX 2016002922A
Authority
MX
Mexico
Prior art keywords
kidney disease
methods
disclosure
renal disease
gfr
Prior art date
Application number
MX2016002922A
Other languages
English (en)
Inventor
Yerramilli Mahalakshmi
V S N Yerramilli Murthy
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52628954&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2016002922(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Publication of MX2016002922A publication Critical patent/MX2016002922A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere a métodos y aparatos para la determinación, diagnóstico, progreso y pronóstico de la enfermedad renal y mortalidad asociada con la enfermedad renal. La descripción incluye un método para determinar la función renal, en particular estimar velocidad de filtración glomerular (GFR), en un animal. La GFR puede ser útil en el diagnóstico y tratamiento de la enfermedad o disfunción renal. En varios aspectos, la descripción se dirige al uso de dimetilarginina simétrica libre (SDMA) y creatinina en muestras de sangre de animales, en particular gatos y perros, para determinar la velocidad de filtración glomerular y enfermedad renal.
MX2016002922A 2013-09-05 2014-09-05 Metodos para la deteccion de enfermedad renal. MX2016002922A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361874011P 2013-09-05 2013-09-05
PCT/US2014/054278 WO2015035155A1 (en) 2013-09-05 2014-09-05 Methods for detecting renal disease

Publications (1)

Publication Number Publication Date
MX2016002922A true MX2016002922A (es) 2016-11-07

Family

ID=52628954

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016002922A MX2016002922A (es) 2013-09-05 2014-09-05 Metodos para la deteccion de enfermedad renal.
MX2021006716A MX2021006716A (es) 2013-09-05 2016-03-04 Metodos in vitro para la deteccion de enfermedad renal.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021006716A MX2021006716A (es) 2013-09-05 2016-03-04 Metodos in vitro para la deteccion de enfermedad renal.

Country Status (20)

Country Link
US (2) US11035861B2 (es)
EP (3) EP3041576B1 (es)
JP (4) JP6657096B2 (es)
KR (2) KR102273028B1 (es)
CN (1) CN105705202B (es)
AU (2) AU2014315063B2 (es)
CA (2) CA2923140C (es)
CY (1) CY1123179T1 (es)
DK (1) DK3041576T3 (es)
ES (2) ES2969979T3 (es)
HR (1) HRP20191569T1 (es)
HU (1) HUE045723T2 (es)
LT (1) LT3041576T (es)
MX (2) MX2016002922A (es)
NZ (1) NZ717554A (es)
PL (1) PL3041576T3 (es)
PT (1) PT3041576T (es)
RS (1) RS59287B1 (es)
SI (1) SI3041576T1 (es)
WO (1) WO2015035155A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3041576B1 (en) 2013-09-05 2019-06-19 IDEXX Laboratories, Inc. Methods for detecting renal disease
KR102492243B1 (ko) 2015-02-20 2023-01-25 아이덱스 래보러토리즈, 인코포레이티드 배경 신호에 대한 보상에 의한 균질 면역검정
MX2017013728A (es) * 2015-04-30 2018-06-07 Idexx Lab Inc Metodos para detectar enfermedad renal.
EP3631472B1 (en) 2017-05-31 2022-07-13 Mars, Incorporated Methods of diagnosing and treating chronic kidney disease
US11026625B2 (en) 2017-08-08 2021-06-08 Fresenius Medical Care Holdings, Inc. Systems and methods for treating and estimating progression of chronic kidney disease
CA3079011A1 (en) * 2017-10-19 2019-04-25 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine
TW202028747A (zh) * 2018-10-17 2020-08-01 日商資生堂股份有限公司 絲球體過濾能力之決定方法
CN109545377B (zh) * 2018-10-22 2021-11-23 中南大学湘雅三医院 获取肾小球滤过率的模型的建立方法
US10745492B1 (en) * 2019-04-03 2020-08-18 Ark Diagnostics, Inc. Antibodies to symmetrically dimethylated arginine analytes and use thereof
CA3152793A1 (en) * 2019-09-05 2021-03-11 The Regents Of The University Of California Noninvasive method to quantify kidney function and functional decline
JP6993654B2 (ja) * 2019-12-27 2022-02-15 Kagami株式会社 腎機能を推定する方法及びシステム
CN112768073B (zh) * 2021-01-15 2023-04-18 中山大学附属第三医院 一种肾小球滤过率估计模型的构建方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134787A1 (de) * 1981-09-02 1983-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim Creatinin-antikoerper
US4818703A (en) 1985-10-23 1989-04-04 Pizzolante John M Stabilized alkaline picrate reagent for jaffe creatinine determination
EP0356160A3 (en) 1988-08-24 1991-09-11 The Board Of Trustees Of The Leland Stanford Junior University Capillary device
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US6455288B1 (en) 1993-04-08 2002-09-24 Dade Behring Marburg Gmbh Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
US5804452A (en) * 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
AU7269098A (en) 1997-05-01 1998-11-24 Cooke Pharma, Inc. Cardiovascular disease risk assessment
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US6358699B1 (en) 1999-02-05 2002-03-19 Cooke Pharma Assay for asymmetrical NG, NG dimethyl-l-arginine
AU2452301A (en) 1999-12-22 2001-07-03 Research Foundation Of The State University Of New York, The Protein methylarginine-specific antibodies
AU2001275870A1 (en) 2000-07-06 2002-01-21 Fal Diagnostics Methods and kits for the detection of arginine compounds
AU2001293699A1 (en) * 2000-07-12 2002-01-21 Werner Naser Direct assessment of analyte to reference molecule ratios
DE10040904A1 (de) 2000-08-18 2002-02-28 Boeger Rainer H Verfahren und Mittel zum Nachweis einer Wahrscheinlichkeit zukünftigen Fortschreitens von Gefässerkrankungen
US7241856B2 (en) 2003-06-02 2007-07-10 Pentron Clinical Technologies Llc Dental resins, dental composite materials, and method of manufacture thereof
JP4214271B2 (ja) 2002-10-15 2009-01-28 アークレイ株式会社 クレアチニン測定用試験片
US7501053B2 (en) 2002-10-23 2009-03-10 Abbott Laboratories Biosensor having improved hematocrit and oxygen biases
AU2003290784A1 (en) 2002-11-15 2004-06-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for detecting asymmetric dimethylarginine in a biological sample
US20050148029A1 (en) 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
ES2332218T3 (es) 2004-11-04 2010-01-29 Germediq Forschungs- Und Entwicklungsgesellschaft Mbh Metodo para la determinacion de arginina, argininas metiladas y sus derivados.
US8698817B2 (en) 2004-11-15 2014-04-15 Nvidia Corporation Video processor having scalar and vector components
US7879979B2 (en) 2005-01-21 2011-02-01 Alere International Arginine analogs, and methods for their synthesis and use
JP2007176872A (ja) 2005-12-28 2007-07-12 Sentan Seimei Kagaku Kenkyusho:Kk アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
ES2547307T3 (es) * 2007-12-05 2015-10-05 King's College London Procedimiento de ayuda al diagnóstico de un trastorno
SI2313364T1 (sl) * 2008-08-07 2021-01-29 Idexx Laboratories, Inc. Metode za detekcijo simetričnega dimetilarginina
RU2559569C2 (ru) * 2009-06-02 2015-08-10 Байокрейтс Лайф Сайенсиз Аг Новые биомаркеры для оценки болезней почек
CN101587118B (zh) * 2009-07-03 2012-09-12 长春迪瑞医疗科技股份有限公司 肌酐尿液分析试纸及制备方法
CN101598727B (zh) * 2009-07-09 2012-10-10 上海科华生物工程股份有限公司 定量测定人体血液尿素含量的干化学试纸
CN101865911A (zh) * 2010-03-16 2010-10-20 苏州市玮琪生物科技有限公司 一种尿肌酐定量检测卡
EP2612147B1 (de) 2010-11-17 2016-03-30 Karl-Heinz Kellner Automatenfähiger immunoassay für biogene amine
JP2012112785A (ja) 2010-11-24 2012-06-14 Tohoku Univ 透析膜の評価方法
JP5925026B2 (ja) * 2011-04-28 2016-05-25 アークレイ株式会社 クレアチニン測定用乾式試験片及びクレアチニン測定法
US20140038203A1 (en) * 2012-07-09 2014-02-06 Musc Foundation For Research Development Methods for detecting or predicting kidney disease
EP3041576B1 (en) 2013-09-05 2019-06-19 IDEXX Laboratories, Inc. Methods for detecting renal disease

Also Published As

Publication number Publication date
CA2923140A1 (en) 2015-03-12
EP4295907A2 (en) 2023-12-27
US20160187348A1 (en) 2016-06-30
JP2016530532A (ja) 2016-09-29
KR102273028B1 (ko) 2021-07-02
AU2014315063B2 (en) 2020-07-23
KR20210082567A (ko) 2021-07-05
AU2020256440B2 (en) 2023-03-02
JP6657096B2 (ja) 2020-03-04
DK3041576T3 (da) 2019-09-09
CA3213810A1 (en) 2015-03-12
EP3480600B1 (en) 2023-11-08
EP3480600A1 (en) 2019-05-08
JP2024020376A (ja) 2024-02-14
LT3041576T (lt) 2019-10-25
ES2969979T3 (es) 2024-05-23
EP4295907A3 (en) 2024-03-13
EP3041576B1 (en) 2019-06-19
US11035861B2 (en) 2021-06-15
ES2746008T3 (es) 2020-03-04
BR112016004839A8 (pt) 2020-02-11
PT3041576T (pt) 2019-09-27
WO2015035155A1 (en) 2015-03-12
SI3041576T1 (sl) 2019-11-29
RS59287B1 (sr) 2019-10-31
KR20160051887A (ko) 2016-05-11
NZ717554A (en) 2022-04-29
AU2014315063A1 (en) 2016-03-17
JP2020073927A (ja) 2020-05-14
HRP20191569T1 (hr) 2019-11-29
CY1123179T1 (el) 2021-10-29
HUE045723T2 (hu) 2020-01-28
AU2020256440A1 (en) 2020-11-12
MX2021006716A (es) 2021-07-15
EP3480600C0 (en) 2023-11-08
US20220137059A1 (en) 2022-05-05
CN105705202B (zh) 2019-02-26
CN105705202A (zh) 2016-06-22
KR102412431B1 (ko) 2022-06-22
EP3041576A4 (en) 2017-07-26
PL3041576T3 (pl) 2019-12-31
EP3041576A1 (en) 2016-07-13
JP2022070879A (ja) 2022-05-13
CA2923140C (en) 2023-09-26

Similar Documents

Publication Publication Date Title
MX2021006716A (es) Metodos in vitro para la deteccion de enfermedad renal.
PL3413708T3 (pl) System i sposób do rejestracji i monitorowania zdrowia i rozwoju żywych ryb
MX2021001694A (es) Sistemas y metodos para proporcionar recomendaciones de bienestar, nutricion y/o salud animal.
NZ749318A (en) System for monitoring pasture intake
BR112015022802A2 (pt) animal não-humano transgênico, progênie do animal, método para identificação de um composto, método para seleção da especificidade ou seletividade de ligação de um composto candidato, célula, tecido ou linhagem celular imortalizada, uso da célula, tecido ou linhagem celular imortalizada, método para identificação de um composto, método para filtragem da especificidade ou seletividade de ligação de um composto candidato, e uso de um composto de fórmula geral
WO2015191777A3 (en) Devices and methods for collecting and stabilizing biological samples
MX2016012133A (es) Determinacion de un indicador de riesgo de salud.
EA201590027A1 (ru) Способы детекции заболеваний или состояний
DK3653049T3 (da) Polynukleotider, der koder for gnaverantistoffer med humane idiotyper, og dyr, der omfatter disse
FR3036830B1 (fr) Systeme et methode pour l'estimation d'un volume de recolte au sein d'une exploitation viticole
BR112017011557A2 (pt) sistema para determinar o estado imune ou ciclo imune, métodos para determinar o estado imune e/ou ciclo imune, para otimizar uma resposta fisiológica, para melhorar uma resposta fisiológica e para determinar um estado imune ou ciclo imune.
EA201390378A1 (ru) Устройство для выявления беременности
BR112014015037A2 (pt) método, sistema e dispositivo eletrônico para determinar a trajetória de um fluxo aquoso, e sonda autônoma
BR112012028284A2 (pt) equipamento de insensibilização de animais para induzir a inconsciência e a insensibilidade substancialmente imediatas permitindo o processamento ou manuseio de um animal, método de insensibilização de um animal para induzir a inconsciência e a insensibilidade substancialmente imediatas permitindo o processamento ou manuseio de um animal, método de manusear e processar um animal, método de abater um animal e equipamento para insensibilização de animais para induzir a inconsciência e a insensibilidade substancialmente imediatas permitindo o processamento ou manuseio de um anima
FR3030774B1 (fr) Procede de determination de parametres d'un filtre de compression et radar multivoies associe
DE112013001973A5 (de) Verfahren und Vorrichtung zur akustischen Ermittlung der Gangart eines Huftieres, insbesondere Nutztieres
FR3018354B1 (fr) Procede d'analyse d'echantillons sedimentaires avec reconnaissance automatique de nannofossiles
WO2015002978A3 (en) Methods for rapid ribonucleic acid fluorescence in situ hybridization
MX2023007778A (es) Metodos para detectar enfermedad renal.
EP2793102A3 (en) Information processing device
WO2016022614A8 (en) Method for evaluating health and genetic predisposition of animals
FR3038091B1 (fr) Procede et dispositif de determination d'une permeabilite au sein d'un reservoir
DE112014001442A5 (de) Vorrichtung zur Vermessung eines Schlachttierkörperobjekts
MX2017010352A (es) Metodos para diagnosticar enfermedad valvular cronica.
TH1701000066A (th) ระบบและวิธีการสำหรับจัดให้มีคำแนะนำเกี่ยวกับสุขภาพโภชนาการ และ/หรือ ความสมบูรณ์แข็งแรงของสัตว์